In the above paragraphs, we have limited discussion to how variability (both genetic and epigenetic) within five genes (APOE, BDNF, ACE, FNDC5, and FTO) might impact on both sarcopenia and AD risk. The gene discussed is APOE; the disease is sarcopenia.